News

The BVA-100 enables measurement of whole blood volume, including plasma volume and red blood cell volume. It also permits measurement of the rate of transudation of albumin across

Ampyra has demonstrated efficacy in people with all four major types of MS (relapsing remitting, secondary progressive, progressive relapsing and primary progressive). Ampyra can be used alone or

ACTB1003 is a novel oral kinase inhibitor that targets cancer cells through multiple modes of action. ACTB1003 inhibits cancer cell growth by targeting the FGF receptor family, which

Biocon is in talks with BiotecCorp to manufacture Biopharmaceutical products and formulation, within Malaysia’s Nusajaya, Iskandar Malaysia, known as Bio-XCell Ecosystem. Biocon is also developing biotechnology infrastructure in

The company claims that Stemcelex naturally stimulates the population of stem cells within the hair follicle. Over 30 years in development, the product is safe and has shown

NicOx is seeking approval for an indication for the relief of the signs and symptoms of primary osteoarthritis. This follows the acceptance for filing of a New Drug

Initially, the company plans to market IoGen through its own retail web site, which is currently being developed by Atech Solutions. In preparation of the launch, Symbollon has

Ofatumumab is a human monoclonal antibody with a mode of action. It targets a part of CD20 molecule encompassing an epitope in the small loop (Teeling et al

As per the current collaboration agreement with the University of Liverpool, HealthLinx licensed in key biomarkers that appear to have utility in the future development of OvPlex ovarian